Literature DB >> 24577747

Effects of cognitive behavioral therapy on insomnia of maintenance hemodialysis patients.

Yongmei Hou1, Peicheng Hu, Yanping Liang, Zhanyu Mo.   

Abstract

The objective of the study was to evaluate the effects of cognitive behavioral therapy [sleep-related behavior modification and progressive muscle relaxation on insomnia of maintenance hemodialysis (MHD) patients] on improving insomnia of MHD patients. 103 MHD patients complicated with insomnia were randomly assigned to treatment (n = 52) and control (n = 51) groups. The control group was treated with conventional hemodialysis, and the treatment group was additionally treated with cognitive behavioral therapy for 3 months (sleep-related behavior modification and progressive muscle relaxation). All cases were assessed by Symptom Checklist 90 (SCL-90) and Pittsburgh Sleep Quality Index (PSQI) before and 2, 4, 6, 8, 10, and 12 weeks after treatment. Fifty-one patients in the treatment group and 47 patients in the control group completed the experiments. After treatment, the total mean scores were (1.94 ± 0.50/2.29 ± 0.31); scores of somatization, depression, anxiety, hostility, and additional items were (1.87 ± 0.58/2.56 ± 0.26), (2.25 ± 0.80/2.79 ± 0.50), (1.79 ± 0.26/2.37 ± 0.34), (1.71 ± 0.46/2.25 ± 0.43), and (1.91 ± 0.67/2.26 ± 0.59) in SCL-90, respectively. The total scores for PSQI were (12.63 ± 2.27/16.40 ± 2.16); scores of subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, hypnotics, and daytime dysfunction which were (1.98 ± 0.76/2.57 ± 0.58), (1.75 ± 0.59/2.60 ± 0.50), (2.10 ± 0.50/2.62 ± 0.53), (2.06 ± 0.47/2.57 ± 0.54), (2.04 ± 0.69/2.45 ± 0.72), (1.02 ± 0.79/1.51 ± 0.98), and (1.69 ± 0.55/2.09 ± 0.58), respectively, were significantly lower in the treatment group compared with the control group. However, there were no significant differences in the scores of factors of obsessive-compulsive (2.26 ± 0.62/2.32 ± 0.38), interpersonal sensitivity (2.23 ± 0.64/2.43 ± 0.47), phobic anxiety (1.98 ± 0.62/2.01 ± 0.67), paranoid ideation (1.55 ± 0.43/1.69 ± 0.39), and psychoticism (1.57 ± 0.46/1.66 ± 0.49). The conclusion is that sleep-related behavior modification in combination with progressive muscle relaxation effectively improved the mental state and sleep quality of MHD patients with insomnia.

Entities:  

Mesh:

Year:  2014        PMID: 24577747     DOI: 10.1007/s12013-014-9828-4

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  13 in total

1.  A Novel Application of a Biopsychosocial Theory in the Understanding of Disturbed Sleep before and after Kidney Transplantation.

Authors:  Jacob M Williams; Christina S McCrae; James R Rodrigue; Pamela R Patton
Journal:  J Clin Sleep Med       Date:  2016-02       Impact factor: 4.062

Review 2.  Sleep Disorders, Restless Legs Syndrome, and Uremic Pruritus: Diagnosis and Treatment of Common Symptoms in Dialysis Patients.

Authors:  Jennifer S Scherer; Sara A Combs; Frank Brennan
Journal:  Am J Kidney Dis       Date:  2016-09-29       Impact factor: 8.860

3.  Symptom Prioritization among Adults Receiving In-Center Hemodialysis: A Mixed Methods Study.

Authors:  Jennifer E Flythe; Tandrea Hilliard; Graciela Castillo; Kourtney Ikeler; Jazmine Orazi; Emaad Abdel-Rahman; Amy Barton Pai; Matthew B Rivara; Wendy L St Peter; Steven D Weisbord; Caroline Wilkie; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-20       Impact factor: 8.237

4.  Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Authors:  Jack D Edinger; J Todd Arnedt; Suzanne M Bertisch; Colleen E Carney; John J Harrington; Kenneth L Lichstein; Michael J Sateia; Wendy M Troxel; Eric S Zhou; Uzma Kazmi; Jonathan L Heald; Jennifer L Martin
Journal:  J Clin Sleep Med       Date:  2021-02-01       Impact factor: 4.062

5.  Zolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis.

Authors:  Magdalene M Assimon; Jennifer E Flythe
Journal:  Clin J Am Soc Nephrol       Date:  2020-12-18       Impact factor: 8.237

Review 6.  Nonpharmacologic Treatments for Opioid Reduction in Patients With Advanced Chronic Kidney Disease.

Authors:  Carrie E Brintz; Martin D Cheatle; Laura M Dember; Alicia A Heapy; Manisha Jhamb; Amanda J Shallcross; Jennifer L Steel; Paul L Kimmel; Daniel Cukor
Journal:  Semin Nephrol       Date:  2021-01       Impact factor: 4.472

7.  Interventions for improving sleep quality in people with chronic kidney disease.

Authors:  Patrizia Natale; Marinella Ruospo; Valeria M Saglimbene; Suetonia C Palmer; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2019-05-26

8.  Do psychological interventions reduce depression in hemodialysis patients?: A meta-analysis of randomized controlled trials following PRISMA.

Authors:  Lu Xing; Ruiqi Chen; Yongshu Diao; Jiahui Qian; Chao You; Xiaolian Jiang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

9.  The SIESTA Trial: A Randomized Study Investigating the Efficacy, Safety, and Tolerability of Acupressure versus Sham Therapy for Improving Sleep Quality in Patients with End-Stage Kidney Disease on Hemodialysis.

Authors:  Kunyu Shen; Yeoungjee Cho; Elaine M Pascoe; Carmel M Hawley; Veronica Oliver; Kathryn M Hughes; Richard Baer; Jeremy Frazier; Elizabeth Jarvis; Ken-Soon Tan; Xusheng Liu; Glenda Gobe; David W Johnson
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-21       Impact factor: 2.629

10.  Depression symptoms and quality of life in patients receiving renal replacement therapy in Jordan: A cross-sectional study.

Authors:  Suhaib Muflih; Karem H Alzoubi; Sayer Al-Azzam; Belal Al-Husein
Journal:  Ann Med Surg (Lond)       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.